Arrowhead Pharmaceuticals Inc (USD)
ARWR
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range44.42 | 45.85
52-Wk Range- | -
Last Close45.15
Mkt Cap (m)4,595.06
Dividend yield-
ISINUS04280A1007
Volume435,316.00
Exchange VenueNAS

Company Profile

Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.

Key Information
Price/Earning501.67
Price/Book9.30
Price/Sales32.38
P/CF-
Rev Growth (3 year avg)921.56
EPS Growth (3 year avg)-
Operating Margin % 36.25
Net Margin %40.27
Return on Equity39.94
Debt/Equity-

Documents

Prospectus
en 05/12/2019
Annual Report
en 30/09/2019

Please refer to the below issuer website for further documents.

https://www.arrowheadpharma.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)0.180.380.1631.4116.14168.80
Operating Income (m)-51.10-95.97-79.69-37.00-55.9461.19
Net Income (m)-58.63-91.94-81.72-34.38-54.4567.97
Basic EPS-1.25-1.60-1.34-0.47-0.650.72
Avg. Diluted Shares Outstanding (m)46.9357.3661.0573.9083.6498.61
Balance Sheet
USD201420152016201720182019
Current Assets (m)154.80102.8790.5067.9078.77265.25
Non Current Assets (m)28.0229.4037.6736.1232.8484.60
Total Assets (m)182.82132.27128.18104.02111.61349.85
Current Liabilities (m)11.8515.9025.6418.7012.3697.07
Total Liabilities (m)------
Total Equity (m)166.54110.1895.5881.4295.80244.59
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-35.42-65.71-64.43-23.94-47.22173.03
Capital Expenditure (m)-1.72-1.97-3.86-7.92-1.42-12.00
Figures are quoted in USD unless stated otherwise
-0.34 (-0.75%)
$
44.81
Last Price